Eder JP - Search Results

1

Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study.

Elias AD, Ayash LJ, Eder JP, Wheeler C, Deary J, Weissman L, Hunt M, Critchlow J, Schnipper L, Frei E 3rd, et al. Elias AD, et al. Among authors: eder jp. J Cancer Res Clin Oncol. 1991;117 Suppl 4:S208-13. doi: 10.1007/BF01613229. J Cancer Res Clin Oncol. 1991. PMID: 1795009 Clinical Trial.

2

Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplant: an analysis of four chemotherapy regimens.

Seiden MV, Elias A, Ayash L, Hunt M, Eder JP, Schnipper LE, Frei E 3rd, Antman KH. Seiden MV, et al. Among authors: eder jp. Bone Marrow Transplant. 1992 Jul;10(1):57-63. Bone Marrow Transplant. 1992. PMID: 1515880

3

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response.

Ayash LJ, Wright JE, Tretyakov O, Gonin R, Elias A, Wheeler C, Eder JP, Rosowsky A, Antman K, Frei E 3rd. Ayash LJ, et al. Among authors: eder jp. J Clin Oncol. 1992 Jun;10(6):995-1000. doi: 10.1200/JCO.1992.10.6.995. J Clin Oncol. 1992. PMID: 1588381

4

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.

Antman K, Ayash L, Elias A, Wheeler C, Hunt M, Eder JP, Teicher BA, Critchlow J, Bibbo J, Schnipper LE, et al. Antman K, et al. Among authors: eder jp. J Clin Oncol. 1992 Jan;10(1):102-10. doi: 10.1200/JCO.1992.10.1.102. J Clin Oncol. 1992. PMID: 1727912 Clinical Trial.

5

A phase I trial of continuous-infusion cyclophosphamide in refractory cancer patients.

Eder JP, Elias AD, Ayash L, Wheeler CA, Shea TC, Schnipper LE, Frei E 3rd, Antman KH. Eder JP, et al. Cancer Chemother Pharmacol. 1991;29(1):61-5. doi: 10.1007/BF00686337. Cancer Chemother Pharmacol. 1991. PMID: 1742850

6

Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.

Teicher BA, Herman TS, Tanaka J, Eder JP, Holden SA, Bubley G, Coleman CN, Frei E 3rd. Teicher BA, et al. Among authors: eder jp. Cancer Res. 1991 Feb 15;51(4):1086-91. Cancer Res. 1991. PMID: 1825474

7

A phase I study of high-dose ifosfamide and escalating doses of carboplatin with autologous bone marrow support.

Elias AD, Ayash LJ, Eder JP, Wheeler C, Deary J, Weissman L, Schryber S, Hunt M, Critchlow J, Schnipper L, et al. Elias AD, et al. Among authors: eder jp. J Clin Oncol. 1991 Feb;9(2):320-7. doi: 10.1200/JCO.1991.9.2.320. J Clin Oncol. 1991. PMID: 1846407 Clinical Trial.

8

A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity.

Eder JP, Wheeler CA, Teicher BA, Schnipper LE. Eder JP, et al. Cancer Res. 1991 Jan 15;51(2):510-3. Cancer Res. 1991. PMID: 1985770

9

High-dose ifosfamide with mesna uroprotection: a phase I study.

Elias AD, Eder JP, Shea T, Begg CB, Frei E 3rd, Antman KH. Elias AD, et al. Among authors: eder jp. J Clin Oncol. 1990 Jan;8(1):170-8. doi: 10.1200/JCO.1990.8.1.170. J Clin Oncol. 1990. PMID: 2104923

10

Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combination.

Teicher BA, Holden SA, Eder JP, Herman TS, Antman KH, Frei E 3rd. Teicher BA, et al. Among authors: eder jp. Semin Oncol. 1990 Feb;17(1 Suppl 3):18-32. Semin Oncol. 1990. PMID: 2106164

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters